|
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (USD $)
In Thousands, except Share data, unless otherwise specified |
12 Months Ended | |
|---|---|---|
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
| Net revenue: | ||
| Product revenues | $ 1,029 | $ 1,127 |
| Licensing revenues | 711 | 680 |
| Total net revenues | 1,740 | 1,807 |
| Cost of goods sold | 898 | 737 |
| Gross margin | 842 | 1,070 |
| Operating expenses: | ||
| Research and development | 826 | 632 |
| Depreciation and amortization | 223 | 151 |
| Selling, general and administrative | 3,110 | 3,620 |
| Total operating expenses | 4,159 | 4,403 |
| Loss from operations | (3,317) | (3,333) |
| Interest income | 0 | 2 |
| Interest expense | (94) | 0 |
| Gain on sale of equipment | 3 | 55 |
| Amortization of debt discount | (257) | 0 |
| Other income (expense) | (33) | 14 |
| Net loss | (3,698) | (3,262) |
| Other comprehensive income, foreign currency translation adjustments | (2) | 27 |
| Total comprehensive loss | $ (3,700) | $ (3,235) |
| Net loss per common share, basic and diluted | $ (0.24) | $ (0.29) |
| Weighted average common shares outstanding, basic and diluted | 15,624,999 | 11,223,878 |